Cat bite antibiotics: could less be more?

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients greater or equal to 18 years of age. * Bitten by a cat. * Location of bite is the hand and/or forearm (distal to elbow). * Presenting \<24 hours following a cat bite to the hand/forearm. * English speaking Exclusion Criteria: * Patients who present with active local or systemic infections 1. Purulent drainage from the cat bite 2. Redness AND swelling at the location of the cat bite * Having a fever \>100.4° F or \>38° C)-Received antibiotics within the past 30 days * Received antibiotics within the past 30 days * Patients unwilling to take study medication * Patients unwilling to attend scheduled follow-up evaluations or complete study forms * Pregnant Women * Type I hypersensitivity reaction to any of the study interventions * Immunocompromised patients (primary and secondary immunodeficiencies) Primary * Autoimmune Lymphoproliferative Syndrome (ALPS) * Autoimmune Polyglandular Syndrome type 1 (APS-1) * B-cell Expansion with Nuclear factor kappa-light-chain-enhancer of activated B cells and T-cell Anergy (BENTA) Disease * Caspase Eight Deficiency State (CEDS) * Caspase Recruitment Domain Family Member 9 (CARD9) Deficiency and Other Syndromes of Susceptibility to Candidiasis * Cartilage-hair hypoplasia * Chédiak-Higashi syndrome * Chronic Granulomatous Disease (CGD) * Common Variable Immunodeficiency (CVID) * Complement Deficiencies * Congenital Neutropenia Syndromes * Cytotoxic T-Lymphocyte Associated Protein 4 (CTLA4) Deficiency * Cyclic neutropenia * DiGeorge syndrome * Dedicator Of Cytokinesis 8 (DOCK8) Deficiency * GATA-binding protein 2 (GATA2) Deficiency * Glycosylation Disorders with Immunodeficiency * Hyper-Immunoglobulin E Syndromes (HIES) * Hyper-Immunoglobulin M Syndromes * Interferon Gamma, Interleukin 12 and Interleukin 23 Deficiencies * Leukocyte Adhesion Deficiency (LAD) Types 1 and 2 * Lipopolysaccharide Responsive Beige-Like Anchor Protein (LRBA) Deficiency * Phosphatidylinositol 3-kinase (PI3-Kinase) Disease * Phospholipase C gamma 2 (PLCG2) associated Antibody Deficiency and Immune Dysregulation (PLAID) * Severe Combined Immunodeficiency (SCID) * Selective Immunoglobulin A (IgA) deficiency * Signal transducer and activator of transcription 3 (STAT3) Dominant-Negative Disease * STAT3 Gain-of-Function Disease * Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome * Wiskott-Aldrich Syndrome (WAS) * X-Linked Agammaglobulinemia (XLA) * X-Linked Lymphoproliferative Disease (XLP) * X-linked magnesium transporter 1 (MAGT1) deficiency with increased susceptibility to Epstein-Barr virus (EBV) infection and N-linked glycosylation defect (XMEN) Disease * Zeta-associated protein 70 (ZAP-70) deficiency Secondary * Malnutrition * Uncontrolled Diabetes mellitus * Chronic uremia * Genetic syndromes: trisomy 21 * Immunomodulatory, immunosuppressive drug therapy: corticosteroids, calcineurin inhibitors, cytotoxic agents * Systemic lupus erythematosus * Malignancy * Active radiation therapy * Bone marrow ablation * Infectious diseases: human immunodeficiency virus (HIV) infection, Hepatitis Additional Primary and secondary immunodeficiencies can be found at the following link. https://www.merckmanuals.com/professional/immunology-allergic-disorders/immunodeficiency-disorders/overview-of-immunodeficiency-disorders